Corporate News     12-Jun-24
Glenmark receives USFDA approval for Esomeprazole Magnesium Delayed-Release Capsules

Glenmark Specialty SA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg (OTC), determined by the FDA to be bioequivalent1 to Nexium®2 24 HR Delayed-Release Capsules, 20 mg (OTC), of Haleon U.S. Holdings LLC. Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg (OTC), will be distributed in the U.S. by Glenmark Therapeutics Inc., USA.

According to Nielsen® syndicated data for the latest 52 weeks period ending 18 May 2024, the Nexium® 24 HR Delayed-Release Capsules, 20 mg (OTC) market achieved annual sales of approximately $259.2 million.

Glenmark's current portfolio consists of 197 products authorized for distribution in the U.S. marketplace and 50 ANDA's pending approval with the U.S. FDA. In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.

Previous News
  Glenmark Pharmaceuticals Ltd soars 0.98%, rises for fifth straight session
 ( Hot Pursuit - 11-Jun-25   13:00 )
  Glenmark Pharma rises after zanubrutinib launch in India
 ( Hot Pursuit - 09-Jun-25   12:02 )
  Glenmark receives DCGI approval to launch oncology drug BRUKINSA in India
 ( Corporate News - 09-Jun-25   11:04 )
  Board of Glenmark Pharmaceuticals recommends final dividend
 ( Corporate News - 24-May-25   11:52 )
  Glenmark Pharmaceuticals reports consolidated net profit of Rs 4.65 crore in the March 2025 quarter
 ( Results - Announcements 24-May-25   07:44 )
  Glenmark Pharmaceuticals grants 1.19 lakh stock options under ESOS
 ( Corporate News - 22-May-25   16:03 )
  Glenmark Pharmaceuticals announces board meeting date
 ( Corporate News - 13-May-25   15:58 )
  Ichnos Glenmark Innovation receives USFDA fast track designation for ISB 2001
 ( Corporate News - 05-May-25   19:16 )
  Glenmark Pharmaceuticals allots 12,653 equity shares under ESOP
 ( Corporate News - 17-Apr-25   20:08 )
  Glenmark Pharma’s US arm set to launch generic Adderall tablets
 ( Hot Pursuit - 17-Apr-25   08:04 )
  Glenmark USA to launch Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets
 ( Corporate News - 16-Apr-25   19:53 )
Other Stories
  Board of Piccadily Agro Industries allots 6.72 lakh equity shares on conversion of warrants
  12-Jun-25   18:12
  Board of Canara Bank approves capital raising plan for FY 2026
  12-Jun-25   18:09
  SG Mart secures orders worth Rs 266 cr
  12-Jun-25   18:02
  Happiest Minds Technologies appoints Anand Balakrishnan as CFO
  12-Jun-25   18:01
  SEPC bags solar power project of Rs 650 cr
  12-Jun-25   17:57
  Galada Finance AGM scheduled
  12-Jun-25   17:51
  Hindustan Unilever to conduct EGM
  12-Jun-25   17:51
  Cyient DLM to hold AGM
  12-Jun-25   17:51
  Safa Systems & Techs. to conduct AGM
  12-Jun-25   17:51
  Atal Realtech to conduct EGM
  12-Jun-25   17:50
Back Top